Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

New Enterprise Associates

New Enterprise Associates
VC INVESTOR TYPE
Active STATUS
55 PROFESSIONALS
2,170 INVESTMENTS
424 PORTFOLIO
814 EXITS
Description

New Enterprise Associates is a venture capital firm that specializes in seed, early stage, growth stage, and pre-IPO investments. The firm seeks to invest in the technology, software services, systems, consumer, internet, energy and healthcare sectors. The firm was founded in 1977 and is headquartered in Chevy Chase, Maryland.

Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1977
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 5425 Wisconsin Avenue
  • Suite 800
  • Chevy Chase, MD 20815
  • United States

+1 (301) 000-0000

New Enterprise Associates Investments (2,170)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Reneo Pharmaceuticals 14-May-2019 Later Stage VC 0000 Drug Discovery Pre-Clinical Trials 000000 0000000
0000000 09-May-2019 00000 00000 0000 Business/Productivity Software Generating Revenue 0000000 00000
00000 000000000000 07-May-2019 000 0000 Drug Discovery Clinical Trials - Phase 2 000000 0000000
00000 30-Apr-2019 00000 00000 00000 Financial Software Generating Revenue 00000 0000000
00000000 26-Apr-2019 00000 00000 0000 Software Development Applications Generating Revenue 0000000 000000000000 00.0
00000000 25-Apr-2019 00000 00000 00000 Educational and Training Services (B2C) Generating Revenue 00000 0000000
000000 25-Apr-2019 00000 00000 0000 Accessories Generating Revenue 0000000 00000
00000000 24-Apr-2019 00000 00000 000 Business/Productivity Software Generating Revenue 00000 0000000000000
The Well (Other Healthcare Services) 23-Apr-2019 Early Stage VC 0000 Other Healthcare Services Generating Revenue
Gen.G 17-Apr-2019 Later Stage VC 0000 Entertainment Software Generating Revenue 0000 0000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore New Enterprise Associates’s full profile, request a free trial.

New Enterprise Associates Exits (809)

Company Name Exit Date Exit Type Exit Size Status Buyers
Clementia Pharmaceuticals 18-Apr-2019 Merger/Acquisition 00.000 Completed
00000000 15-Apr-2019 0000000000: 000000 Completed
00000000 26-Mar-2019 000000000000000000 Completed
  • 000000000
0000000 13-Mar-2019 000000000000000000 Completed
  • 00 000000000000000
00000 11-Mar-2019 000000000000000000 00000 Completed
  • 00 00000000
00000 06-Mar-2019 000000000000000000 Completed
  • 00000000 000
0000 000000000000 01-Mar-2019 000000000000000000 Completed
  • 000000000
000000 07-Feb-2019 000000000000000000 Completed
  • 000 00 0000000
Luxtera 07-Feb-2019 Merger/Acquisition 00000 Completed
  • Cisco Systems
Tesaro 22-Jan-2019 Merger/Acquisition 00.00 Completed
To view this investor’s complete exits history, request access »

New Enterprise Associates Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore New Enterprise Associates‘s full profile, request access.

Request full access to PitchBook

New Enterprise Associates Team (159)

Name Title Deals Funds Boards Office Contact
Info
Timothy Schaller Chief Financial Officer & Chief Operating Officer Washington, DC
Bala Deshpande Senior Managing Director 00 0 0 Mumbai, India
Ruchir Lahoty Managing Director 0 0 0 Mumbai, India
Tarun Sharma Managing Director 0 0 0 Mumbai, India
Scott Sandell Managing General Partner 00 00 00 Menlo Park, CA

76 Former Team Members

You’re viewing 5 of 159 team members. Get the full list »

New Enterprise Associates Co-Investors (1,534)

Name With Exits Lead Partner
Accel 16 0 00
Australia Future Fund 00 00
Correlation Ventures 00 0 0
GV 00 0 00
Kleiner Perkins 00 0 00
To view this investor’s complete co-investor history, request access »